Friday, July 11, 2014

Senators Query Hepatitis C Drug’s High Costs by REUTERS

Abogado Aly Blog Post



By REUTERS


Two members of the Senate Finance Committee asked Gilead Sciences to defend the more than $80,000 cost of Sovaldi, citing the expense to federal health care programs.


Published: July 12, 2014 at 4:00AM


from NYT U.S. http://ift.tt/1sJ0TtX






from WordPress http://ift.tt/1mHQ36c

No comments:

Post a Comment